Mei Ji

1.8k total citations
68 papers, 1.3k citations indexed

About

Mei Ji is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Mei Ji has authored 68 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 26 papers in Pulmonary and Respiratory Medicine and 14 papers in Molecular Biology. Recurrent topics in Mei Ji's work include Lung Cancer Treatments and Mutations (14 papers), Cancer Immunotherapy and Biomarkers (14 papers) and Gastric Cancer Management and Outcomes (8 papers). Mei Ji is often cited by papers focused on Lung Cancer Treatments and Mutations (14 papers), Cancer Immunotherapy and Biomarkers (14 papers) and Gastric Cancer Management and Outcomes (8 papers). Mei Ji collaborates with scholars based in China, United States and Japan. Mei Ji's co-authors include Jingting Jiang, Hong‐Xiang Lou, Xiongyao Xie, Weiqing Zhao, Changping Wu, Hongbing Shi, Changping Wu, Huiqing Yuan, Qing Li and Jun Wu and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Nature Cell Biology.

In The Last Decade

Mei Ji

67 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mei Ji China 21 485 267 238 226 118 68 1.3k
Zheng Cao China 19 369 0.8× 478 1.8× 258 1.1× 148 0.7× 268 2.3× 89 1.3k
Jiahua Yang China 18 182 0.4× 428 1.6× 162 0.7× 77 0.3× 141 1.2× 58 936
Jiliang Wang China 21 152 0.3× 521 2.0× 120 0.5× 85 0.4× 224 1.9× 80 1.2k
Xiaoqiang Yue China 18 179 0.4× 427 1.6× 117 0.5× 73 0.3× 201 1.7× 39 1.1k
Ning Meng China 20 62 0.1× 570 2.1× 57 0.2× 114 0.5× 295 2.5× 71 1.3k
Sanghee Kang South Korea 19 360 0.7× 425 1.6× 151 0.6× 95 0.4× 181 1.5× 71 1.1k
Xiaoyan Cui United States 16 265 0.5× 313 1.2× 171 0.7× 112 0.5× 168 1.4× 43 1.0k
Chih‐Ching Yeh Taiwan 24 195 0.4× 471 1.8× 95 0.4× 98 0.4× 140 1.2× 78 1.6k
Guiming Zhang China 19 243 0.5× 491 1.8× 275 1.2× 85 0.4× 289 2.4× 112 1.2k
Jincheng Wang China 21 241 0.5× 516 1.9× 177 0.7× 189 0.8× 210 1.8× 70 1.3k

Countries citing papers authored by Mei Ji

Since Specialization
Citations

This map shows the geographic impact of Mei Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mei Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mei Ji more than expected).

Fields of papers citing papers by Mei Ji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mei Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mei Ji. The network helps show where Mei Ji may publish in the future.

Co-authorship network of co-authors of Mei Ji

This figure shows the co-authorship network connecting the top 25 collaborators of Mei Ji. A scholar is included among the top collaborators of Mei Ji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mei Ji. Mei Ji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zhang, Fan, et al.. (2024). TBK1 is paradoxical in tumor development: a focus on the pathway mediating IFN-I expression. Frontiers in Immunology. 15. 1433321–1433321. 5 indexed citations
3.
Sun, Zhe, Yanli Shi, Mei Ji, et al.. (2024). The quest for nanoparticle-powered vaccines in cancer immunotherapy. Journal of Nanobiotechnology. 22(1). 61–61. 35 indexed citations
4.
Yao, Xue, et al.. (2023). Tumor-associated macrophages mediate resistance of EGFR-TKIs in non-small cell lung cancer: mechanisms and prospects. Frontiers in Immunology. 14. 1209947–1209947. 17 indexed citations
5.
Zhu, Ding, Fan Zhang, Yan Li, et al.. (2023). 86P Efficacy and safety of HLX07 monotherapy in advanced cutaneous squamous cell carcinoma: An open-label, multicentre phase II study. Annals of Oncology. 34. S1500–S1500. 1 indexed citations
7.
Shi, Hongbing, et al.. (2020). <p>Hepatic Arterial Infusion Combined with Systemic Chemotherapy for Patients with Extensive Liver Metastases from Gastric Cancer</p>. Cancer Management and Research. Volume 12. 2911–2916. 2 indexed citations
8.
Duan, Xuejing, Zhiyong Lin, Xiujuan Lin, et al.. (2018). Study of platelet‐rich fibrin combined with rat periodontal ligament stem cells in periodontal tissue regeneration. Journal of Cellular and Molecular Medicine. 22(2). 1047–1055. 39 indexed citations
9.
Zhao, Jiemin, Liangrong Shi, Mei Ji, Jun Wu, & Changping Wu. (2017). The combination of systemic chemotherapy and local treatment may improve the survival of patients with unresectable metastatic colorectal cancer. Molecular and Clinical Oncology. 6(6). 856–860. 6 indexed citations
10.
Zhu, Danxia, Cheng Fang, Mei Ji, et al.. (2015). Prognostic value of interim (18)F-FDG-PET in diffuse large B cell lymphoma treated with rituximab-based immune-chemotherapy: a systematic review and meta-analysis.. PubMed. 8(9). 15340–50. 5 indexed citations
11.
Nagai, Yasuhiro, E. Aaron Runkle, Mei Ji, et al.. (2015). Disabling of the erbB Pathway Followed by IFN-γ Modifies Phenotype and Enhances Genotoxic Eradication of Breast Tumors. Cell Reports. 12(12). 2049–2059. 19 indexed citations
12.
Li, Zhengguang, Jun Wu, Mei Ji, et al.. (2014). Prognostic role of lemur tyrosine kinase 3 in postoperative gastric cancer. Molecular and Clinical Oncology. 2(5). 756–760. 10 indexed citations
13.
Zhao, Weiqing, Xiaodong Li, Hongbing Shi, et al.. (2014). CD40 mutant expression and its clinical significance to prognosis in gastric cancer patients. World Journal of Surgical Oncology. 12(1). 167–167. 1 indexed citations
14.
Ji, Mei, Xiaodong Li, Hanze Zhang, et al.. (2014). Report of clinical studies on chronochemotherapy for advanced non-small cell lung cancer in China. Tumor Biology. 35(12). 12285–12292. 1 indexed citations
15.
Shi, Liangrong, Jun Wu, Wenjie Zhou, Mei Ji, & Hongyu Zhang. (2013). CT-guided 125I seed implantation for locoregional lymph node metastases in patients with recurrent gastric cancer. 33(4). 243–247. 1 indexed citations
16.
Ji, Mei, Qiang Li, Hua Ji, & Hong‐Xiang Lou. (2013). Investigation of the distribution and season regularity of resveratrol in Vitis amurensis via HPLC–DAD–MS/MS. Food Chemistry. 142. 61–65. 34 indexed citations
17.
Ni, Xuefeng, Ping Wu, Changping Wu, et al.. (2013). Treatment of cervical vertebral (C1) metastasis of lung cancer with radiotherapy: A case report. Oncology Letters. 5(4). 1129–1132. 2 indexed citations
18.
Li, Xiaodong, Changping Wu, Mei Ji, et al.. (2013). Characteristic analysis of α-fetoprotein-producing gastric carcinoma in China. World Journal of Surgical Oncology. 11(1). 246–246. 27 indexed citations
19.
Wang, Xiaoning, et al.. (2009). Lobarialides A–C, Antifungal Triterpenoids from the Lichen Lobaria kurokawae. Chemistry & Biodiversity. 6(5). 746–753. 19 indexed citations
20.
Lou, Hong‐Xiang, Huiqing Yuan, Bin Ma, et al.. (2004). Polyphenols from peanut skins and their free radical-scavenging effects. Phytochemistry. 65(16). 2391–2399. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026